Description
During the pandemic, the need to develop therapeutic approaches became critical and so the need to study them in a structured way to critically evaluate their effectiveness. Innovative strategies to conduct clinical trials under difficult circumstances were required. We will discuss these strategies with some people who created them!
Objectives:
• Understand the main challenges to conduct clinical trials in the middle of a pandemic both in the developed and developing world
• Discuss strategies for patient recruitment and evaluation.
• Deliberate on future strategies to study new therapies for emerging pathogens.
Guests:
• David Boulware, MD MPH. Professor of Medicine and Infectious Diseases, University of Minnesota.
• Eduardo López-Medina, MD. Assistant Professor of Pediatrics at Universidad del Valle, and Director of Pediatric Infectious Diseases, Centro Medico Imbanaco, Cali Colombia.
We can probably all agree that any false positive test result is bad, but I think it’s safe to say that some false positives, like a false positive HIV test for example, is much more anxiety provoking than others. And when it comes to HIV, there have been a number of key advances in the field...
Published 02/24/23
Novel β-lactamase/β-lactamase inhibitors have become critical drugs to combat the most resistant Gram-negative infections. A series of new compounds with even more broad and potent activity are in the horizon to add to the therapeutic armamentarium. Today, we will discuss these drugs with experts...
Published 02/10/23